ECNP e-news
34th ECNP Congress: meet the keynote speaker
ECNP School Virtual 2021: deadline to apply is today!
New Frontiers Meeting Virtual 2021: apply now!
ENA Award: call for nominations
ECNP Rising Star Award
Latest updates from the ECNP TWGs
Discover the AIMS-2-TRIALS EU project
The Brain Prize Meeting 2021
Contact ECNP
To the website
34th ECNP Congress Lisbon

Meet the keynote speaker

Ray Dolan, United Kingdom has been confirmed as our keynote speaker for the 34th ECNP Congress, 2-5 October 2021!

Ray Dolan is Mary Kinross Professor of Neuropsychiatry and Director of the Max Planck-UCL Centre for Computational Psychiatry and Ageing. Fellow of the Royal Society and co-recipient of the 2017 Brain Prize, he has been ranked by Semantic Scholar as the second-most influential neuroscientist in the modern world.

His research interests include the neural mechanisms of reward, learning and decision making, and how impairment in these relate to neuropsychiatric disorders.

He will present the lecture entitled 'How we build internal models of the world'.

We are looking forward to welcoming Ray Dolan to the ECNP Congress!

ECNP School Virtual: last chance to apply

Have you already applied for the ECNP School of Child and Adolescent Neuropsychopharmacology Virtual, 24-26 March 2021?

Don't wait too long, you only have today 12 January to apply!

ECNP apply here

A select number of participants will be offered an interactive meeting with an international faculty of experts in basic and clinical paediatric neuropsychopharmacology.

Further information about this ECNP School is available here.

We are looking forward to receive your application!

ECNP New Frontiers in Digital Health Meeting

ECNP New Frontiers Meeting Virtual

Application deadline approaching

On 8 and 9 March 2021 ECNP organises the third New Frontiers in Digital Health Meeting Virtual.

Topics are:

  • Digital therapeutics – a false dawn or a real option for patients?
  • How do we gain regulatory approval for a digital biomarker or therapeutic?
  • Optimising clinical trials with digital tools – pitfalls and promises

Apply now if you would like to join! 

ECNP apply here

The deadline is tomorrow 13 January.

This meeting is designed for all representatives from IT, pharma and medical devices industry, regulators, and patient and family associations who are interested in discussing different points of view on how digital health is going to change the way clinical trials are run and the use of digital therapeutics for brain disorders.

ECNP Neuropsychopharmacology Award

EUR 10,000 award in pre-clinical research 

Only a few days left to submit nominations for the ECNP Neuropsychopharmacology Award!

The deadline is 15 January.

The ECNP Neuropsychopharmacology Award recognises exceptional research achievements in applied and translational neuroscience.

The 2021 award will be in pre-clinical research.

The award winner will be honoured with:

Find out more on who is eligible and how to nominate.


ECNP Rising Star Award

Only a few days left!

15 January is also the deadline to nominate for the ECNP Rising Star Award.

This award honours an early career researcher in applied and translational neuroscience with the potential to advance the science of treatment and prevention of brain disorders.

What can you win?
An unrestricted prize of € 2,000, a commemorative certificate and an invitation to the 34th ECNP Congress, 2-5 October 2021 with faculty benefits for travel and hotel. The award is conferred duiring the ECNP Congress.
Don't miss this opportunity!

More information
Pharmacogenomics and Transcriptomics ECNP Thematic Working Group

2020 highlights of ECNP TWGs

Great news!

The ECNP Pharmacogenomics and Transcriptomics Thematic Working Group (TWG), chaired by Bernhard Baune, has been awarded an ERA PerMed grant called PROMPT “Toward PrecisiOn Medicine for the Prediction of Treatment response in major depressive disorder through stratification of combined clinical and -omics signatures”.
Additional congratulations on the publication of the group’s book Personalised Psychiatry on biliogical psychiatry with an emphasis on genomics and transcriptomics.

Visit this page for more information about the ECNP Networks and TWGs.
AIMS-2-TRIALS EU-funded project supported by ECNP

AIMS-2-TRIALS: latest news

AIMS-2-TRIALS is a landmark European research initiative that explores the biology of autism – how it develops across the lifespan, and how this varies in different people – to identify biological markers, to tailor treatments and to develop new medicines.

Amongst the project’s articles published in 2020 are:

AIMS-2-TRIALS, funded under the Innovative Medicines Initiative 2 Joint Undertaking, is one of the EU research projects supported by ECNP. More info about other EU projects can be found here.

Lundbeck Foundation

Registration for the 2021 Brain Prize Meeting open

The 2021 Brain Prize meeting, ‘Neurodevelopmental Disorders: Mechanisms and pathways to treatment’ will be held virtually on 1-4 March 2021.

Confirmed speakers include leaders from across the fields of epigenetics, regulation of gene expression, neuronal and circuit dysfunction, diagnosis, and pathways to treatment of neurodevelopmental disorders.

The virtual meeting is free to attend, and all sessions will be live to encourage dialogue and discussion amongst participants. To register, click here.

Follow us on
Facebook, Twitter & Instagram
Facebook Twitter instagram